Brief: Cytokinetics Presents New Data Related To Aficamten
29/09/2025 12:41
Sept 29 (Reuters) - Cytokinetics Inc CYTK.O: CYTOKINETICS PRESENTS NEW DATA RELATED TO AFICAMTEN AT THE HFSA ANNUAL SCIENTIFIC MEETING 2025 Source text: ID:nGNX4XMvm Further company coverage: CYTK.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytokinetics, Incorporated
See all newsBrief: Cytokinetics To Announce Third Quarter Results On November 4, 2026
Brief: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Cytokinetics Announces Additional Data From Acacia-Hcm Presented At The Hfsa Annual Scientific Meeting 2026
Brief: Cytokinetics Launches Aspen-Hcm A Real-World Study Evaluating Myqorzo® (Aficamten) In Symptomatic Obstructive Hypertrophic Cardiomyopathy
U.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech